ENHANCE: Safety and Efficacy of Seladelpar in Patients With Primary Biliary Cholangitis—A Phase 3, International, Randomized, Placebo-Controlled Study

Antzeko izenburuak

• Results of a Phase 2, Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Saroglitazar Magnesium in Patients With Primary Biliary Cholangitis (EPICS)
  Argitaratua: (2021)
• Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy
  nork: Wah-Suarez, Martin I, et al.
  Argitaratua: (2019)
• A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
  nork: Kowdley, Kris V., et al.
  Argitaratua: (2020)
• A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis
  nork: Mayo, Marlyn J., et al.
  Argitaratua: (2019)
• GLIMMER Trial—A Randomized, Double-Blind, Placebo-Controlled Study of Linerixibat, an Inhibitor of the Ileal Bile Acid Transporter, in the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis
  Argitaratua: (2021)